A Leader in Ion Channel Drug Discovery

As a biotech company working with globally recognized pharmaceutical companies, Icagen leverages its Ion Channel Technology Platform to enable the discovery of ion channel targeting therapeutics.

Advancing Discovery Programs via Versatile Technology

Novel discoveries in ion channel science are creating a need for targeted approaches to various indications. Icagen’s Ion Channel Technology™ provides a differentiated capability for advancing high value ion channel and transporter drug discovery programs.

Team with More than a Century of Combined Pharmaceutical Experience

Icagen’s forward-looking leadership team is comprised of dedicated scientists and experts who want to advance medical discoveries through ion channel technology. The leadership team seeks to leverage our proprietary technologies in innovative ways.

Contact Us

Address

1035 Swabia Court
Suite 110
Newcastle North
Durham , NC 27703

    Your Full Name *

    Your Email Address *

    Your Message *

    Press Release | 12.21.2020

    LIGAND AND GSK ENTER GLOBAL COLLABORATION AND LICENSE AGREEMENT LEVERAGING ICAGEN’S DISCOVERY TECHNOLOGY TO TARGET NEUROLOGICAL DISORDERS